Marcel Blommers

Marcel Blommers

Company: Saverna Therapeutics

Job title: Chief Scientific Officer

Seminars:

Live Panel Q&A – Ask the Speakers your Burning Questions 4:15 pm

Read more

day: Day One

Revealing Fragment-Based Screening Approaches Using NMR Demonstrates the Druggability of Biologically Active RNA 3:35 pm

• Discuss how NMR-based fragment screening demonstrates the druggability of biologically active RNAs • Outlining how SMN2 splice modulators can enhance pre-mRNA association and rescue SMA mice • Evaluating the utility of fragment-screening library-NMR-based quality controlRead more

day: Day One

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.